Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Sissoko, Mahamadou S ^a   Dabo, Abdoulaye ^a   Traoré, Hamidou ^a   Diallo, Mouctar ^a   Traoré, Boubacar ^a   Konaté, Drissa ^a   Niaré, Boubacar ^a   Diakité, Moussa ^a   Kamaté, Bourama ^a   Traoré, Abdrahamane ^a   Bathily, Aboudramane ^a   Tapily, Amadou ^a   Touré, Ousmane B ^a   Cauwenbergh, Sarah ^b   Jansen, Herwig F ^b   Doumbo, Ogobara K ^a  

^a UNIVERSITY OF BAMAKO   (Mali)

^b Dafra Pharma International   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ARTESUNATE; ASPARTATE AMINOTRANSFERASE; CREATININE; HEMOGLOBIN; METAKELFIN; PLACEBO; PRAZIQUANTEL; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; PYRIMETHAMINE; SULFALENE;

ABDOMINAL PAIN; ADOLESCENT; ANOREXIA; ANUS PRURITUS; ARTICLE; BIOCHEMISTRY; BLOOD EXAMINATION; BRONCHITIS; BURNING SENSATION; CHILD; CHILL; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; COUGHING; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE COUNT; FEMALE; FURUNCULOSIS; HEMATOCRIT; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERSALIVATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NAUSEA; OTITIS; PALLOR; PRESCHOOL CHILD; PRURITUS; RHINORRHEA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SKIN DISEASE; SKIN INFECTION; SORE THROAT; THORAX PAIN; THROMBOCYTE COUNT; URINALYSIS; VOMITING; WORM EGG; WOUND; ANIMAL; DRUG COMBINATION; METABOLISM; TIME;

ARTESUNATE; SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM;

ADOLESCENT; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; PRAZIQUANTEL; PYRIMETHAMINE; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SULFALENE; TIME FACTORS;

EID: 70350012305     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006732     Document Type: Article

References (35)

1. WHO (1993) The control of schistosomiasis: second report of the WHO expert committee. WHO Technical Reports series, No 830, WHO: Geneva, 1993.
2. Doumengue JP, Mott KE, Cheng C, Villenave D, Chapuis O, et al. (1987) Atlas of the global distribution of schistosomiasis, WHO: Geneva, 1987.
3. Intergovernmental Panel on Climate Change (IPCC) Climate change 2001: third assessment report, impacts, adaptations and vulnerability of climate change. McCarthy JJ, et al. Eds. Cambridge, UK, Cambridge University Press, 2001.
4. Stelma FF, Talla I, Sow S, Kongs A, Niang M, et al. (1995) Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg 53: 167-170.
5. Guissé F, Polman K, Stelma FF, Mbaye A, Talla I, et al. (1997) Therapeutic evaluation of two different regimens of praziquantel in a recent Schistosoma mansoni focus in Northern Senegal. Am J Trop Med Hyg 56: 511-514.
6. Klayman DL, Qinghaosu (artemisinin) (1985): an antimalarial drug from China. Science 228: 1049-55.
7. Kirsten E. Lyke, Alassane Dicko, Abdoulaye Dabo, Lansana Sangare, Abdoulaye Kone, et al. (2005) Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am J Trop Med Hyg 73(6): 1124-1130.
8. Xiao SH, Catto BA (1989) In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother 33: 1557-62.
9. Xiao SH, Utzinger J, Chollet J, Tanner M (2006) Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both. - Int J Parasitol 36(8): 957-64.
10. Utzinger J, Chollet J, You J, Mei J, Tanner M, et al. (2001) Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals - Acta Trop 1; 80(1): 9-18.
11. Utzinger J, Xiao SH, Tanner M, Keiser J (2007) Artemisinins for schistosomiasis and beyond. Curr Opin Invest Drugs 2007 8(2): 105-116.
12. Utzinger J, Keiser J, Xiao SH, Tanner M, Singer BH (2003) Combination chemotherapy for schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47(5): 1487-1495.
13. Inyang-Etoh PC, Ejezie GC, Useh MF, Inyang-Etoh EC (2004) Efficacy of artesunate in the treatment of urinary schistosomiasis in an endemic community in Nigeria. Ann Trop Med Par 98(5): 491-499.
14. Adam I, Elhardello OA, Elhadi MO, Abdalla E, Elmardi KA, et al. (2008) The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated Plasmodium falciparum malaria. Ann Trop Med Parasitol 102 (1): 39-44.
15. Boulanger D, Dieng Y, Cisse B, Remoue F, Capuano F, et al. (2007) Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks. Trans R Soc Trop Med Hyg 101(2): 113-116.
16. Danso-Appiah A, Utzinger J, Liu J, Olliaro P (2008) Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev. 2008 Jul 16(3): CD000053.
17. Sissoko K (2005) Impact de l'infection à Schistosoma haematobium sur les paramètres paludométriques dans un village d'endémie palustre au Mali. Thèse Médecine 47.
18. Sagara I, Rulisa S, Mbacham W, Adam I, Sissoko K, et al. (2009) Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial. Malaria Journal 8: 63.
19. Danso-Appiah A, Garner P, Olliaro PL, Utzinger J (2009) Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review. Parasitology 136: 1-13.
20. Wegner, D.H.G. (1984) The profile of the trematodicidal compound praziquantel. Arzneimittelforschung 34: 1132-1136.
21. Gryseels B, Nkulikyinka L, Coosemans MH (1987) Field trials of praziquantel and oxaminiquine for the treatment of Schistosoma mansoni in Burundi. Trans R Soc Trop Med Hyg 81: 641-644.
22. WHO (2005) Scientific Working Group Report on Schistosomiasis. ;Word Health Organization, Geneva, WHO/TDR/SWG/07.
23. Gryseels B, Mbaye A, De Vlas SJ, Stelma FF, Guisse F, et al. (2001) Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop Med Int Health 6: 864-873.
24. Midzi N, Sangweme D, Zinyowera S, Mapingure MP, Brouwer KC, et al. (2008) Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Trans R Soc Trop Med Hyg 102: 759-766.
25. Joako WG, Muchemi G, Oguya FO (1996) Praziquantel side effects during treatment of Schistosoma mansoni infected pupils in Kibwezi, Kenya. East Afr Med J 73, (8): 499-501.
26. Berte N, Gundersen SG, Abebe F, Birrie H, Medhin G, et al. (1999) Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia. Acta Trop 72: 53-63.
27. Sagara I, Dicko A, Djimde A, Guindo O, Koné M, et al. (2006) A randomized trial of Artesunate-Sulfamethoxypyrazine-Pyrimethamine versus Artemether-Lumefantrine for the treatment of uncomplicated Plasmodium Falciparum Malaria in Mali. Am J Trop Med Hyg 75 (4): 630-636.
28. Clercq D, Vercruysse J, Kongs A, Verle P, Dompnier JP, et al. (2002) Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren. Acta Trop 82: 61-66.
29. WHO (2002b) Report of the Informal Consultation on the use of praziquantel during Pregnancy/Lactation and Albendazole/Mebendazole in Children under 24 months. World Health Organization, Geneva, WHO/CDC/CPE/ PVC/2002.4.
30. Raso G, N'Goran EK, Toty A, Luginbühl A, Adjoua CA, et al. (2004) Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire. Trans R Soc Trop Med Hyg 98: 18-27.
31. Kimura E, Kamou GM, Kiliku FM, Muhoho ND, Waiyaki PG, et al. (1992) Side effects of praziquantel in the treatment of urinary schistosomiasis in Kenya. Trop Med34: 91-96.
32. Kabatereine NB, Kimijumbi J, Ouma JH, Sturock RF, Butterworth AE, et al. (2003) Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at lake Albert, Uganda. Trans R Soc Trop Med Hyg 97: 599-603.
33. Nmorsi OP, Ukwandu NC, Ogoinja S, Blackie HO, Odike MA (2007) Urinary tract pathology in Schistosoma haematobium infected rural Nigerians. Southeast Asian J Trop Med Public Health 38(1): 32-7.
34. Brouwer KC, Ndhlovu PD, Wagatsuma Y, Munatsi A, Shiff CJ (2003) Epidemiological assessment of Schistosoma haematobium-induced kidney and bladder pathology in rural Zimbabwe. Acta Trop 85(3): 339-47.
35. Kouriba B, Traore HA, Dabo A, Sangare L, Guindo H, et al. (2005) Urinary disease in 2 Dogon populations with different exposure to Schistosoma haematobium infection: progression of bladder and kidney diseases in children and adults. J Infect Dis 15; 192(12): 2152-9.